Navigation Links
World Anticoagulants Market to Exceed $12 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
Date:10/30/2008

Driven by patent expiries, development of novel therapeutics, and the rapidly aging population, the world market for anticoagulants is projected to exceed $12 billion by 2015. With just two therapy classes - vitamin K antagonist and heparin injectables, dominating the market, there exist enormous opportunities and interest in developing advanced, patient friendly anticoagulants.

San Jose, CA (PRWEB) October 30, 2008 -- The unmet medical needs of available anticoagulants offer ample scope for development in the world anticoagulants market. Continuous research and development is expected to result in novel therapies with superior therapeutic efficiency, and minimum side effects. These advanced therapeutics offer promising market prospects. Exanta, for instance, represents a cutting edge direct thrombin inhibitor that flaunts the potential to kindle demand patterns, dethrone warfarin's dominance, and challenge the supremacy of low molecular weight heparins. Identification of new indications for existing, and emerging therapies is expected to help open up brighter prospects for further growth.

Factor Xa inhibitors (oral and injectable) and direct thrombin inhibitors (oral and injectable) are among the new class of thrombin antagonists that are being evaluated for both existing as well as newer indications. Development of products for specific market niches, like, anticoagulation therapies for ischemic stroke, is additionally expected to result in expanded opportunities. Patent expiries of drugs like "Coumadin" offer a lucrative business case for generic drug manufacturers. Favorable demographic patterns, like the rapidly aging world population is expected to drive demand patterns, given the tendency of aging individuals to develop various venous and arterial complications.

The United States dominates the world anticoagulants market, with a share of nearly 50%, as stated by Global Industry Analysts, Inc. Strong double digit growth is expected to stem from the injectable anticoagulants market, with the United States setting the pace of growth with projected CAGR in excess of 15.1% over the period of 2000 through 2010. Market for injectable anticoagulants is dominated by low molecular weight heparin (LMWH). Strong growth in LMWH market is expected to push sales of injectable anticoagulants to US$6.6 billion by 2010. Japanese oral anticoagulants market is estimated to be worth US$38.3 million. In Europe, France represents the largest market with a 23.8% share.

Major market participants profiled include AstraZeneca PLC, Barr Laboratories Inc., Bristol-Myers Squibb Company, Celgene Corporation, GlaxoSmithKline plc, Mitsubishi Tanabe Pharma Corporation, Pfizer Inc., and Sanofi-Aventis.

The report titled "Anticoagulants: A Global Strategic Business Report" published by Global Industry Analysts, Inc., provides a comprehensive review of market trends, drivers, issues, challenges, and research and development activities. Richly annotated with authoritative, and unbiased commentaries, and hard-to-find statistical facts, the report provides unequivocal views on future potential while throwing light on the prevailing climate in key regional markets. Product markets analyzed in the report include Oral, and Injectable (Unfractionated Heparin, and Low Molecular Weight Heparin). Latent demand patterns in product markets are quantified across major geographic market verticals including the United States, Japan, France, Germany, United Kingdom, Italy, and Spain, among others for the period 2000-2015. Also provided in the report is an enumeration of recent mergers, acquisitions, and other strategic industry activities.

For more details about this research report, please visit
http://www.strategyr.com/Anticoagulants_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs more than 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of more than 60,000 smaller research products including company reports, market trend reports and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press@StrategyR.com
Web Site http://www.StrategyR.com/

###

Read the full story at http://www.prweb.com/releases/anticoagulants/injectable_oral/prweb1542674.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Repair and healing of osteoporotic fractures a focus of upcoming IOF World Congress on Osteoporosis
2. Considering Revision Surgery? Board Certified Plastic Surgeon and Washington DC-based Dr. Mark E. Richards Pioneers Facelift Revisions Attracting Patients Worldwide
3. WorldHeart Announces Effectiveness of Reverse Stock Split
4. Our cheatin brain: The brains clever way of showing us the world as a whole
5. Several US Children Among Worldwide Heroes for Inspirational Fundraising Efforts with Celine Dion
6. World Biochips Market to Reach $3.4 billion by 2012, According to New Report by Global Industry Analysts, Inc.
7. University Of Minnesota Gives 11,538 Flu Shots Tuesday, Shattering Guinness World Record for Most Flu Shots in a Single Day
8. National Psoriasis Foundation Seeks 10,000 Americans to Support Psoriasis Research for World Psoriasis Day
9. The Wireless World: Untethered Opportunities
10. This Holiday Season, Give a Gift that Does a World of Good
11. HTH Worldwide Unveils First Digital Healthcare Card
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
World Anticoagulants Market to Exceed $12 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief ... a minimum wage raise to $12 an hour by 2020 and then adjusting it yearly ... lost value of the minimum wage, assure the wage floor does not erode again, and ...
(Date:6/24/2016)... Georgia (PRWEB) , ... June 24, 2016 , ... ... awards today at the Clinical Decision Making in Emergency Medicine conference in Ponte ... have authored journal articles published in Emergency Medicine Practice and Pediatric ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
(Date:6/24/2016)... ... ... recruitment firm Slone Partners is pleased to announce the placement of Suzanne ... of North American Capital Sales at HTG Molecular . , In ... commercialization of the HTG EdgeSeq system and associated reagents in North America. , Headquartered ...
(Date:6/24/2016)... ... 24, 2016 , ... Today, MTI-GlobalStem, a provider of optimized ... difficult to transfect cells, announces its launch of the PluriQ™ G9™ Gene Editing ... is a complete system for culturing and transfecting human pluripotent stem cells ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016  Guerbet announced today that it has been ... Award . One of 12 suppliers to ... its support of Premier members through exceptional local customer ... commitment to lower costs. ... our outstanding customer service from Premier," says Massimo ...
(Date:6/23/2016)... , June 23, 2016  Experian ... integrating and transforming the patient payment and ... several innovative new products and services that ... its revenue cycle offerings. These award-winning solutions ... efficient workflows, remain compliant in an ever-changing ...
(Date:6/23/2016)... , June 23, 2016 Leading BioSciences ... address medical conditions resulting from a breakdown of ... appointed Greg Doyle as chief executive ... BioSciences, executive management team and board of directors, ... financial officer. He will provide continued leadership and ...
Breaking Medicine Technology: